Allostery Investments LP Kal Vista Pharmaceuticals, Inc. Transaction History
Allostery Investments LP
- $7.85 Billion
- Q2 2025
A detailed history of Allostery Investments LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 40,000 shares of KALV stock, worth $490,000. This represents 5.76% of its overall portfolio holdings.
Number of Shares
40,000
Previous 458,302
91.27%
Holding current value
$490,000
Previous $5.29 Billion
91.45%
% of portfolio
5.76%
Previous 7.63%
Shares
3 transactions
Others Institutions Holding KALV
# of Institutions
146Shares Held
54.1MCall Options Held
986KPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$82.4 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$60.7 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$57.3 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...